| Dr Brent Mazoch, MD | |
|
3223 8th St, Metairie, LA 70002-1623 | |
| (504) 833-7770 | |
| (504) 833-7782 |
| Full Name | Dr Brent Mazoch |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 35 Years |
| Location | 3223 8th St, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205938511 | NPI | - | NPPES |
| 1914401 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 004536 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lane Regional Medical Center | Zachary, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Baton Rouge Emergency Physicians Group, Llc | 8426382243 | 12 |
News Archive
BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime's ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.
The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.
As the 9th Annual Health 2.0 Fall Conference rapidly approaches, Health 2.0 is excited to announce confirmed speakers at the inaugural Innovating Care Delivery Symposium. The day-long session features an agenda with executives and providers from some of the most progressive health systems in the nation, including UCLA, UCSF, Stanford, Henry Ford, and many others.
A team of scientists from the United Kingdom has recently revealed the therapeutic benefits of histamine receptor antagonists in reducing long-term symptoms of coronavirus disease 2019 (COVID-19). They have also indicated that T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary between asymptomatic COVID-19 and long-COVID.
› Verified 9 days ago
| Entity Name | C & M Medical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710903059 PECOS PAC ID: 9436061553 Enrollment ID: O20050121000093 |
News Archive
BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime's ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.
The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.
As the 9th Annual Health 2.0 Fall Conference rapidly approaches, Health 2.0 is excited to announce confirmed speakers at the inaugural Innovating Care Delivery Symposium. The day-long session features an agenda with executives and providers from some of the most progressive health systems in the nation, including UCLA, UCSF, Stanford, Henry Ford, and many others.
A team of scientists from the United Kingdom has recently revealed the therapeutic benefits of histamine receptor antagonists in reducing long-term symptoms of coronavirus disease 2019 (COVID-19). They have also indicated that T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary between asymptomatic COVID-19 and long-COVID.
› Verified 9 days ago
| Entity Name | East Baton Rouge Emergency Physicians Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255894952 PECOS PAC ID: 8426382243 Enrollment ID: O20190628000232 |
News Archive
BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime's ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.
The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.
As the 9th Annual Health 2.0 Fall Conference rapidly approaches, Health 2.0 is excited to announce confirmed speakers at the inaugural Innovating Care Delivery Symposium. The day-long session features an agenda with executives and providers from some of the most progressive health systems in the nation, including UCLA, UCSF, Stanford, Henry Ford, and many others.
A team of scientists from the United Kingdom has recently revealed the therapeutic benefits of histamine receptor antagonists in reducing long-term symptoms of coronavirus disease 2019 (COVID-19). They have also indicated that T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary between asymptomatic COVID-19 and long-COVID.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brent Mazoch, MD 3223 8th St, Metairie, LA 70002-1623 Ph: (504) 833-7770 | Dr Brent Mazoch, MD 3223 8th St, Metairie, LA 70002-1623 Ph: (504) 833-7770 |
News Archive
BioTime, Inc. announced today that on June 1, 2010 the Company will be offering for sale five new human stem cell lines for research use only. These cell lines were developed using BioTime's ACTCellerate™ technology. These highly purified, novel, and scalable cell lines are embryonic progenitors, meaning that they are intermediate between human embryonic stem cells and fully developed cells.
The findings, which appear in the July issue of the journal Molecular Cancer Therapeutics, could lead to a treatment that provides an effective option to surgically removing the cancer, helping patients preserve vital organs involved in speech and swallowing.
As the 9th Annual Health 2.0 Fall Conference rapidly approaches, Health 2.0 is excited to announce confirmed speakers at the inaugural Innovating Care Delivery Symposium. The day-long session features an agenda with executives and providers from some of the most progressive health systems in the nation, including UCLA, UCSF, Stanford, Henry Ford, and many others.
A team of scientists from the United Kingdom has recently revealed the therapeutic benefits of histamine receptor antagonists in reducing long-term symptoms of coronavirus disease 2019 (COVID-19). They have also indicated that T cell immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary between asymptomatic COVID-19 and long-COVID.
› Verified 9 days ago
Dr. Michael C Grieb, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Houma Blvd, Emergency Room, Metairie, LA 70006 Phone: 210-614-0180 Fax: 210-566-5698 | |
Theodore A. Irra, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3434 Houma Blvd, Suite 200, Metairie, LA 70006 Phone: 504-458-6061 Fax: 504-866-0206 | |
Dr. David Henry Melton, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3131 North I-10 Service Road East, Suite 308, Metairie, LA 70002 Phone: 504-833-7770 Fax: 504-833-7796 | |
Dr. Carl Zalokoski Mcallister, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 4200 Houma Blvd, Emergency Department, Metairie, LA 70006 Phone: 504-454-4196 | |
Dr. Cristobal Mandry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3223 8th St, Metairie, LA 70002 Phone: 504-833-7770 Fax: 504-833-7782 | |
Dr. Terry Creel, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Houma Blvd, Emergency Department, Metairie, LA 70006 Phone: 210-614-0180 Fax: 210-566-5698 | |
Barbara L. Cohn, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4901 Lake Louise Avenue, Metairie, LA 70006 Phone: 504-491-2957 Fax: 504-456-7224 |